{
    "ticker": "OPGN",
    "name": "OpGen, Inc.",
    "description": "OpGen, Inc. is a precision medicine company that leverages its proprietary technology to improve patient outcomes through the detection and treatment of infectious diseases. Founded in 2001, OpGen aims to combat the growing threat of antibiotic resistance by providing advanced genomic solutions that help healthcare providers ensure effective treatment options. The company's flagship product, the Acuitas Diagnostics platform, enables rapid identification of pathogens and their resistance profiles directly from patient samples. This can significantly reduce the time to diagnosis and optimize antibiotic treatment, ultimately enhancing patient care. OpGen is committed to delivering innovative diagnostics and treatments that align with the principles of personalized medicine. The company's efforts are focused on developing next-generation sequencing and bioinformatics solutions that provide actionable insights for healthcare professionals. Furthermore, OpGen collaborates with various healthcare institutions and research organizations to expand its offerings and impact in the field of infectious diseases. With a mission to transform the way infections are diagnosed and treated, OpGen is at the forefront of addressing one of the most pressing challenges in modern medicine.",
    "industry": [
        "Biotechnology",
        "Healthcare"
    ],
    "headquarters": "Rockville, Maryland, USA",
    "founded": "2001",
    "website": "https://www.opgen.com",
    "ceo": "J. Craig Kapp",
    "social_media": {
        "twitter": "https://twitter.com/OpGenInc",
        "linkedin": "https://www.linkedin.com/company/opgen-inc/"
    },
    "investor_relations": "https://investors.opgen.com",
    "key_executives": [
        {
            "name": "J. Craig Kapp",
            "position": "CEO"
        },
        {
            "name": "M. Scott T. Morrison",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Diagnostic Solutions",
            "products": [
                "Acuitas Diagnostics",
                "Acuitas Lighthouse"
            ]
        }
    ],
    "seo": {
        "meta_title": "OpGen, Inc. | Precision Medicine and Infectious Disease Solutions",
        "meta_description": "Explore OpGen, Inc., a leader in precision medicine focused on combating antibiotic resistance through innovative diagnostic solutions.",
        "keywords": [
            "OpGen",
            "Precision Medicine",
            "Infectious Diseases",
            "Antibiotic Resistance",
            "Genomic Solutions"
        ]
    },
    "faq": [
        {
            "question": "What does OpGen do?",
            "answer": "OpGen specializes in precision medicine, focusing on diagnostics and treatments for infectious diseases."
        },
        {
            "question": "Who is the CEO of OpGen?",
            "answer": "J. Craig Kapp is the CEO of OpGen, Inc."
        },
        {
            "question": "Where is OpGen headquartered?",
            "answer": "OpGen is headquartered in Rockville, Maryland, USA."
        },
        {
            "question": "What are OpGen's main products?",
            "answer": "OpGen's main products include the Acuitas Diagnostics platform and Acuitas Lighthouse."
        },
        {
            "question": "When was OpGen founded?",
            "answer": "OpGen was founded in 2001."
        }
    ],
    "competitors": [
        "IDXX",
        "QGEN",
        "EXAS"
    ],
    "related_stocks": [
        "AMGN",
        "GILD",
        "BMY",
        "ABBV"
    ]
}